Please select the option that best describes you:

Are the cardiac risks of LHRH agonists also seen in patients undergoing bilateral orchiectomy for ADT in hormone-sensitive prostate cancer?  



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more